R.PR
REGISTERED-PRINCIPAL REGISTER
01/18/2022
Back to search
Official data from USPTO
ARRAKIS THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
01/18/2022
Trademark type
Combined
Nice classes
42
Filing date
10/20/2020
Registration date
01/18/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/18/2022
Last transaction
01/18/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2020-04-00
First use in commerce
2020-04-00
Drawing code
3
Owner type
03
Owner location
Waltham, MA
Examiner
RONCORONI, LAUREN
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of three differently sized sets of concentric circles, with a thick striped line connecting the first and second circles and the second and third circles. The wording "Arrakis Therapeutics" appears to the right of the design, with "arrakis" in large, prominent, lowercase type above and "therapeutics" in smaller, all-capitalized type below.
Holders and representatives
Holders
Arrakis Therapeutics, Inc
Representatives
Glenn A. Gundersen DECHERT LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development in the pharmaceutical field; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
15 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/02/2021
PUBO
PUBLISHED FOR OPPOSITION
11/02/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/13/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/28/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/27/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/27/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/27/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/27/2021
GNRT
NON-FINAL ACTION E-MAILED
03/27/2021
CNRT
NON-FINAL ACTION WRITTEN
03/27/2021
DOCK
ASSIGNED TO EXAMINER
03/20/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/09/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/08/2020
NWAP
NEW APPLICATION ENTERED
10/23/2020
Continuous trademark protection
Get notified about every new filing that threatens ARRAKIS THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.